STAT3 and epilepsy: In search for a pharmacological intervention that could target the epileptogenic processes underlying TLE, our prior findings in the PILO rat model of epilepsy indicated that administration of the STAT3 inhibitor WP1066 at the time of SE reduced the number of spontaneous seizures after the latent period [31].